RLX Q1 Results: Major Drop Seen

MarketBusiness by Leona Zhu, Ellesmere Zhu

May.17.2023

RLX Q1 Results: Major Drop Seen

RLX Technology reports significant revenue drop and net loss for Q1 2023, compared to 2022.

On May 17, RLX Technology (NYSE: RLX) released its financial results for the first quarter of 2023 ending on March 31st.

The report revealed a net revenue of CNY 188.9 million (approximately USD 27.5 million), a drastic drop of 89% compared to the same period last year, which stood at CNY 1.7145 billion.

The company also suffered a net loss of CNY 56.3 million (approximately USD 8.2 million), a significant downturn from the net profit of CNY 687.1 million in Q1 of 2022.

Thumbnail source: Bloomberg

Also Read:

[1] Flavored Vapes Crucial for Adult Smokers' Transition, Says Relx

[2] RELX Leads in Patents: 900 Global Applications

[3] RELX: German Market to See Further Growth

[4] RELX Sees 10% Growth in Middle East and North Africa Markets

[5] RELX Vapes Seized by Regulator Possibly due to Incomplete Docs

[6] What's Behind RELX's Monthly 76% Stock Gains?

[7] RELX Pixel Debuts in Indonesia

[8] RELX Launches New Pod Device in Indonesia

#North America #United States #Disposable e-cigarettes #Regulation

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

2026 InterTabac Special Coverage

2026 InterTabac Special Coverage

Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift

Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift

According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.

Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure

Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure

The Washington Examiner published an opinion article by Tricia McLaughlin, former Assistant Secretary for Public Affairs and spokesperson at the U.S. Department of Homeland Security, arguing that the Trump administration is strengthening enforcement against illegal vape supply chains through the FDA, CBP, and DHS.

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit

The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit

FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.

FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products

FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products

The FDA issued warning letters to eight retailers selling unauthorized nicotine pouches and dissolvable tobacco products resembling candy, breath strips and cough drops. The action highlights rising scrutiny of packaging, youth appeal and accidental ingestion risks, as the agency clarifies enforcement priorities for unauthorized ENDS and nicotine pouch products while maintaining PMTA as the legal market pathway.

Related Topics

Related Read

Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift

Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift

Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure

Former DHS Spokesperson Analyzes CBP’s $175 Million Illegal Vape Seizure

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products

FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products